BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 33808190)

  • 1. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
    Di Martino MT; Riillo C; Scionti F; Grillone K; Polerà N; Caracciolo D; Arbitrio M; Tagliaferri P; Tassone P
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
    Vishnubalaji R; Shaath H; Elango R; Alajez NM
    Semin Cancer Biol; 2020 Oct; 65():65-79. PubMed ID: 31733291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review.
    Volovat SR; Volovat C; Hordila I; Hordila DA; Mirestean CC; Miron OT; Lungulescu C; Scripcariu DV; Stolniceanu CR; Konsoulova-Kirova AA; Grigorescu C; Stefanescu C; Volovat CC; Augustin I
    Front Oncol; 2020; 10():526850. PubMed ID: 33330019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs as novel immunotherapeutic tools against cancer.
    Kaur M; Kaur B; Konar M; Sharma S
    Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.
    Zhou Z; Wang Z; Gao J; Lin Z; Wang Y; Shan P; Li M; Zhou T; Li P
    Mol Ther Oncolytics; 2022 Jun; 25():98-120. PubMed ID: 35506150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs.
    Li LJ; Leng RX; Fan YG; Pan HF; Ye DQ
    Exp Cell Res; 2017 Dec; 361(1):1-8. PubMed ID: 29031633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer.
    Guo T; Li J; Zhang L; Hou W; Wang R; Zhang J; Gao P
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):31-48. PubMed ID: 30417217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
    Pang B; Hao Y
    Front Oncol; 2021; 11():690486. PubMed ID: 34178688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer.
    Yang S; Sun Z; Zhou Q; Wang W; Wang G; Song J; Li Z; Zhang Z; Chang Y; Xia K; Liu J; Yuan W
    Cancer Manag Res; 2018; 10():2249-2257. PubMed ID: 30100756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
    Tang XJ; Wang W; Hann SS
    Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications.
    Shahzad U; Krumholtz S; Rutka JT; Das S
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33800703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA-miRNA interactions.
    Bian EB; Xiong ZG; Li J
    J Cell Physiol; 2019 Mar; 234(3):2194-2203. PubMed ID: 30229908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in breast cancer.
    Lo PK; Wolfson B; Zhou X; Duru N; Gernapudi R; Zhou Q
    Brief Funct Genomics; 2016 May; 15(3):200-21. PubMed ID: 26685283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA loss in immune suppression in cancer.
    Hu Q; Egranov SD; Lin C; Yang L
    Pharmacol Ther; 2020 Sep; 213():107591. PubMed ID: 32473960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.
    Wei L; Sun J; Wang X; Huang Y; Huang L; Han L; Zheng Y; Xu Y; Zhang N; Yang M
    Front Cell Dev Biol; 2023; 11():1226639. PubMed ID: 37560164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles and mechanisms of the lncRNA-miRNA axis in the progression of esophageal cancer: a narrative review.
    Huang T; Wu Z; Zhu S
    J Thorac Dis; 2022 Nov; 14(11):4545-4559. PubMed ID: 36524088
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.